X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4802) 4802
Book Review (1247) 1247
Publication (173) 173
Magazine Article (31) 31
Book Chapter (15) 15
Book / eBook (10) 10
Conference Proceeding (9) 9
Dissertation (4) 4
Reference (2) 2
Streaming Video (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4391) 4391
index medicus (4384) 4384
antiparkinson agents - adverse effects (3132) 3132
parkinson disease - drug therapy (3103) 3103
antiparkinson agents - therapeutic use (2631) 2631
male (2514) 2514
female (2228) 2228
parkinson's disease (2039) 2039
clinical neurology (2011) 2011
middle aged (1889) 1889
aged (1885) 1885
levodopa - adverse effects (1745) 1745
levodopa - therapeutic use (1259) 1259
antiparkinson agents - administration & dosage (1014) 1014
neurosciences (1008) 1008
levodopa (960) 960
animals (820) 820
adult (798) 798
parkinson disease - physiopathology (784) 784
pharmacology & pharmacy (689) 689
treatment outcome (682) 682
levodopa - administration & dosage (609) 609
parkinson disease - complications (596) 596
drug therapy, combination (568) 568
abridged index medicus (537) 537
dose-response relationship, drug (486) 486
dopamine (457) 457
dopa (456) 456
double-blind (447) 447
antiparkinson agents - pharmacology (444) 444
parkinsons-disease (444) 444
dyskinesia, drug-induced - etiology (442) 442
neurology (432) 432
aged, 80 and over (429) 429
motor fluctuations (420) 420
l-dopa (405) 405
psychiatry (399) 399
double-blind method (397) 397
dopamine agonists - therapeutic use (391) 391
parkinsons disease (380) 380
dopamine agonists - adverse effects (378) 378
parkinson disease - therapy (373) 373
severity of illness index (360) 360
dyskinesia (359) 359
parkinson disease - psychology (357) 357
time factors (354) 354
parkinson disease - diagnosis (332) 332
rats (312) 312
drug therapy (295) 295
movement disorders (282) 282
therapy (282) 282
risk factors (275) 275
drug combinations (267) 267
disease models, animal (265) 265
dyskinesia, drug-induced - drug therapy (263) 263
basal ganglia (261) 261
analysis (257) 257
drug administration schedule (250) 250
antiparkinson agents - pharmacokinetics (248) 248
follow-up studies (244) 244
antipsychotic agents - adverse effects (239) 239
deep brain stimulation (227) 227
parkinson disease (225) 225
disease (220) 220
dyskinesia, drug-induced - physiopathology (217) 217
parkinsonian disorders - drug therapy (217) 217
quality of life (214) 214
subthalamic nucleus (212) 212
care and treatment (210) 210
carbidopa - adverse effects (208) 208
levodopa-induced dyskinesias (206) 206
medicine, general & internal (206) 206
pramipexole (206) 206
carbidopa - therapeutic use (205) 205
dopamine - metabolism (204) 204
parkinson disease - metabolism (204) 204
motor activity - drug effects (199) 199
retrospective studies (199) 199
dyskinesias (193) 193
research (191) 191
surgery (191) 191
carbidopa - administration & dosage (190) 190
dopamine agonists (190) 190
clinical trials as topic (186) 186
disease progression (183) 183
antiparkinsonian agents (181) 181
antipsychotic agents - therapeutic use (176) 176
drug interactions (175) 175
parkinson disease - epidemiology (173) 173
pharmacokinetics (172) 172
ropinirole (172) 172
dopamine agents - adverse effects (169) 169
neurologic examination - drug effects (166) 166
dopamine agonists - administration & dosage (164) 164
dementia (162) 162
levodopa - pharmacology (159) 159
rats, sprague-dawley (157) 157
levodopa-induced dyskinesia (152) 152
prevalence (152) 152
levodopa - pharmacokinetics (151) 151
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (9) 9
Online Resources - Online (3) 3
Baycrest Hospital - Stacks (1) 1
Baycrest Hospital - Wellness Library (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4328) 4328
German (137) 137
Spanish (97) 97
French (95) 95
Japanese (50) 50
Russian (31) 31
Dutch (25) 25
Hungarian (17) 17
Polish (12) 12
Danish (11) 11
Italian (11) 11
Norwegian (6) 6
Chinese (5) 5
Finnish (5) 5
Romanian (5) 5
Swedish (5) 5
Portuguese (4) 4
Czech (3) 3
Serbian (2) 2
Hebrew (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2013, Volume 368, Issue 7, pp. 610 - 622
Journal Article
Annals of Neurology, ISSN 0364-5134, 07/2010, Volume 68, Issue 1, pp. 18 - 27
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 06/2013, Volume 123, Issue 6, pp. 2730 - 2736
Journal Article
Science, ISSN 0036-8075, 11/2007, Volume 318, Issue 5854, pp. 1309 - 1312
Deep brain stimulation (DBS) of the subthalamic nucleus markedly improves the motor symptoms of Parkinson's disease, but causes cognitive side effects such as... 
Neurology | Basal ganglia | Health outcomes | Deep brain stimulation | Parkinson disease | Medications | Thalamus | Reports | Lesions | Behavioral neuroscience | Modeling | CHOICE | SUBTHALAMIC NUCLEUS | REACTION-TIME | OPTIMAL DECISION-MAKING | BASAL GANGLIA | MULTIDISCIPLINARY SCIENCES | DISEASE | DOPAMINE | HIGH-FREQUENCY STIMULATION | COGNITIVE CONTROL | SELECTION | Parkinson Disease - therapy | Impulsive Behavior - etiology | Humans | Middle Aged | Male | Reaction Time | Deep Brain Stimulation - adverse effects | Dopamine Agents - therapeutic use | Antiparkinson Agents - therapeutic use | Dopamine Agents - adverse effects | Learning | Levodopa - administration & dosage | Conflict (Psychology) | Female | Dopamine Agents - administration & dosage | Neural Networks (Computer) | Decision Making | Levodopa - therapeutic use | Reinforcement (Psychology) | Parkinson Disease - physiopathology | Parkinson Disease - psychology | Antiparkinson Agents - adverse effects | Basal Ganglia - physiology | Subthalamic Nucleus - physiology | Levodopa - adverse effects | Aged | Antiparkinson Agents - administration & dosage | Models, Neurological | Parkinsonism | Psychological aspects | Physiological aspects | Brain stimulation | Impulse | Health aspects | Brain | Side effects | Cognition & reasoning | Medical treatment | Parkinsons disease | Drug therapy | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9923, pp. 1138 - 1146
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 08/2014, Volume 85, Issue 8, pp. 840 - 845
Journal Article
Journal Article
Brain, ISSN 0006-8950, 2005, Volume 128, Issue Part 10, pp. 2240 - 2249
Deep brain stimulation (DBS) is associated with significant improvement of motor complications in patients with severe Parkinson's disease after some 6-12... 
Subthalamic nucleus | Parkinson's disease | Deep brain stimulation | Globus pallidus pars interna | Long-term effects | NONHUMAN-PRIMATES | SURGERY | SUBTHALAMIC NUCLEUS STIMULATION | long-term effects | BASAL GANGLIA | GLOBUS-PALLIDUS | NEUROSCIENCES | deep brain stimulation | globus pallidus pars interna | CLINICAL NEUROLOGY | LEVODOPA | MOVEMENT-DISORDERS | MOTOR FLUCTUATIONS | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | subthalamic nucleus | COMPLICATIONS | Parkinson Disease - therapy | Motor Activity - physiology | Dyskinesia, Drug-Induced - physiopathology | Follow-Up Studies | Humans | Middle Aged | Male | Parkinson Disease - drug therapy | Deep Brain Stimulation - adverse effects | Activities of Daily Living | Antiparkinson Agents - therapeutic use | Time Factors | Adult | Female | Globus Pallidus - physiopathology | Subthalamic Nucleus - physiopathology | Levodopa - therapeutic use | Brain - physiopathology | Treatment Outcome | Electrodes, Implanted | Parkinson Disease - physiopathology | Antiparkinson Agents - adverse effects | Dyskinesia, Drug-Induced - therapy | Deep Brain Stimulation - methods | Levodopa - adverse effects | Aged | Index Medicus | Abridged Index Medicus | Levodopa/adverse effects/therapeutic use | Antiparkinson Agents/adverse effects/therapeutic use | Globus Pallidus/physiopathology | Parkinson Disease/drug therapy/physiopathology/therapy | Motor Activity/physiology | Brain/physiopathology | Dyskinesia; Drug-Induced/physiopathology/therapy | Subthalamic Nucleus/physiopathology | Deep Brain Stimulation/adverse effects/methods | Electrodes; Implanted
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2006, Volume 355, Issue 9, pp. 896 - 908
Journal Article
Journal Article